» Articles » PMID: 31159345

Mesenchymal Stem Cells for Spinal Cord Injury: Current Options, Limitations, and Future of Cell Therapy

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2019 Jun 5
PMID 31159345
Citations 164
Authors
Affiliations
Soon will be listed here.
Abstract

Spinal cord injury (SCI) constitutes an inestimable public health issue. The most crucial phase in the pathophysiological process of SCI concerns the well-known secondary injury, which is the uncontrolled and destructive cascade occurring later with aberrant molecular signaling, inflammation, vascular changes, and secondary cellular dysfunctions. The use of mesenchymal stem cells (MSCs) represents one of the most important and promising tested strategies. Their appeal, among the other sources and types of stem cells, increased because of their ease of isolation/preservation and their properties. Nevertheless, encouraging promise from preclinical studies was followed by weak and conflicting results in clinical trials. In this review, the therapeutic role of MSCs is discussed, together with their properties, application, limitations, and future perspectives.

Citing Articles

Scientific Advances in Neural Regeneration After Spinal Cord Injury.

Gartit M, Noumairi M, Rhoul A, Mahla H, El Anbari Y, El Oumri A Cureus. 2025; 17(2):e78630.

PMID: 40062077 PMC: 11890103. DOI: 10.7759/cureus.78630.


Synergistic restoration of spinal cord injury through hyaluronic acid conjugated hydrogel-polydopamine nanoparticles combined with human mesenchymal stem cell transplantation.

Kao Y, Song W, Zhang R, Gu G, Qiu H, Shen W Bioact Mater. 2025; 46:569-581.

PMID: 40027446 PMC: 11871414. DOI: 10.1016/j.bioactmat.2024.09.027.


Spinal cord injury repair based on drug and cell delivery: From remodeling microenvironment to relay connection formation.

Ma W, Li X Mater Today Bio. 2025; 31:101556.

PMID: 40026622 PMC: 11871491. DOI: 10.1016/j.mtbio.2025.101556.


Advancements in Antioxidant-Based Therapeutics for Spinal Cord Injury: A Critical Review of Strategies and Combination Approaches.

Shen Y, Huang Y, Cheng Y Antioxidants (Basel). 2025; 14(1).

PMID: 39857350 PMC: 11763222. DOI: 10.3390/antiox14010017.


Macropinocytosis enhances foamy macrophage formation and cholesterol crystallization to activate NLRP3 inflammasome after spinal cord injury.

Zhang C, Zhao S, Huang Z, Xue A, Liu H, Dai S Redox Biol. 2024; 79():103469.

PMID: 39700693 PMC: 11723182. DOI: 10.1016/j.redox.2024.103469.


References
1.
McDonald J, Liu X, Qu Y, Liu S, Mickey S, Turetsky D . Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med. 1999; 5(12):1410-2. DOI: 10.1038/70986. View

2.
Grandpre T, Nakamura F, Vartanian T, Strittmatter S . Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 2000; 403(6768):439-44. DOI: 10.1038/35000226. View

3.
Beattie M, Li Q, Bresnahan J . Cell death and plasticity after experimental spinal cord injury. Prog Brain Res. 2000; 128:9-21. DOI: 10.1016/S0079-6123(00)28003-5. View

4.
Cao Q, Zhang Y, Howard R, Walters W, Tsoulfas P, Whittemore S . Pluripotent stem cells engrafted into the normal or lesioned adult rat spinal cord are restricted to a glial lineage. Exp Neurol. 2001; 167(1):48-58. DOI: 10.1006/exnr.2000.7536. View

5.
Fournier A, Grandpre T, Strittmatter S . Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 2001; 409(6818):341-6. DOI: 10.1038/35053072. View